SCHEMBL7793096

SCHEMBL7793096

CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2CCC

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 13/20 0.84
CYP1A2 P05177 3/20 0.84
PMP22 Q01453 3/20 0.84
LMNA P02545 2/20 0.84
NFKB1 P19838 2/20 0.84
ACHE P22303 2/20 0.84
BLM P54132 2/20 0.84
ESR1 P03372 1/20 0.84
MAPT P10636 1/20 0.84
PDE4B Q07343 12/20 0.70
PDE4C Q08493 12/20 0.70
PDE4D Q08499 12/20 0.70
ADORA2A P29274 5/20 0.68
ADORA2B P29275 4/20 0.68
RXFP1 Q9HBX9 2/20 0.62
MAPK1 P28482 1/20 0.62
TNF P01375 2/20 0.61
USP2 O75604 1/20 0.61
TSHR P16473 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7802893 0.96 PDE4A (0.83) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL7793146 0.95 PDE4A (0.81) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL10873386 0.93 PDE4A (0.77) PDE4ACYP1A2PMP22LMNANFKB1
Propentofylline SCHEMBL74602 0.92 PDE4A (1.00) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL7802154 0.92 PDE4A (0.75) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL7800905 0.91 PDE4A (0.98) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL7800770 0.90 PDE4A (0.76) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL7800864 0.89 PDE4A (0.91) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL27534112 0.89 PDE4A (0.68) PDE4ACYP1A2PMP22LMNANFKB1
SCHEMBL11456819 0.89 PDE4A (0.77) PDE4ACYP1A2PMP22LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0811623-B1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AG (DE) 2001-04-04 EP disclosed
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 US disclosed
EP-0811623-A1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP disclosed